Dual targeting of the tRNA nucleotidyltransferase in plants : not just the signalVON BRAUN, Serena Schmidt; SABETTI, Antonino; HANIC-JOYCE, Pamela J et al.Journal of experimental botany. 2007, Vol 58, Num 15-16, pp 4083-4093, issn 0022-0957, 11 p.Article

Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinomaBARKER, S. D; DMITRIEV, I. P; NETTELBECK, D. M et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 14, pp 1198-1204, issn 0969-7128, 7 p.Article

ZD6126: A novel small molecule vascular targeting agentBLAKEY, David C; ASHTON, Susan E; WESTWOOD, F. Russell et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1497-1502, issn 0360-3016, 6 p.Conference Paper

Les agents anti-infectieux sous forme encapsuléeBOSSERAY, A.La Lettre de l'infectiologue. 1990, Vol 5, Num 1, pp 35-36, issn 0296-9009, 2 p.Article

Live cell imaging fails to support viral-protein-mediated intercellular traffickingFUQING WU; JING LONG; SHUAI WANG et al.Archives of virology. 2012, Vol 157, Num 7, pp 1383-1386, issn 0304-8608, 4 p.Article

Rigorous multiple utility targeting in heat exchanger networksCASTIER, Marcelo.Energy conversion and management. 2012, Vol 59, pp 74-85, issn 0196-8904, 12 p.Article

The development of combretastatin a4 phosphate as a vascular targeting agentCHAPLIN, David J; HILL, Sally A.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1491-1496, issn 0360-3016, 6 p.Conference Paper

Intracellular organelle-targeted non-viral gene delivery systemsWON, Young-Wook; LIM, Kwang Suk; KIM, Yong-Hee et al.Journal of controlled release. 2011, Vol 152, Num 1, pp 99-109, issn 0168-3659, 11 p.Conference Paper

Bone-targeting glycol and NSAIDS ester prodrugs of rhein: Synthesis, hydroxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studiesJIN CAI; YANBING DUAN; JIA YU et al.European journal of medicinal chemistry. 2012, Vol 55, pp 409-419, issn 0223-5234, 11 p.Article

Prioritizing payment for environmental services: Using nonmarket benefits and costs for optimal selectionDUKE, Joshua M; DUNDAS, Steven J; JOHNSTON, Robert J et al.Ecological economics (Amsterdam). 2014, Vol 105, pp 319-329, issn 0921-8009, 11 p.Article

Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targetingDELAHOUSSAYE, Yvette M; HAY, Michael P; PRUIJN, Frederik B et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1807-1815, issn 0006-2952, 9 p.Article

Use of M₁-M₅ muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic systemBYMASTER, Frank P; MCKINZIE, David L; FELDER, Christian C et al.Neurochemical research. 2003, Vol 28, Num 3-4, pp 437-442, issn 0364-3190, 6 p.Article

Exploiting the differential production of angiogenic factors within the tumor microenvironment in the design of a novel vascular-targeted gene therapy-based approach to the treatment of cancerCARPENITO, Carmine; DAVIS, Peter D; DOUGHERTY, Shona T et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1473-1478, issn 0360-3016, 6 p.Conference Paper

Synergy between vascular targeting agents and antibody-directed therapyPEDLEY, R. Barbara; EL-EMIR, Ethaar; FLYNN, Aiden A et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1524-1531, issn 0360-3016, 8 p.Conference Paper

A simple genotyping assay for the Hprt null allele in mice produced from the HM-1 and E14TG2a mouse embryonic stem cell linesMCEWAN, Carolanne; MELTON, David W.Transgenic research. 2003, Vol 12, Num 4, pp 519-520, issn 0962-8819, 2 p.Article

Combination of vascular targeting agents with thermal or radiation therapyHORSMAN, Michael R; MURATA, Rumi.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1518-1523, issn 0360-3016, 6 p.Conference Paper

Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapyBREIDENBACH, M; REIN, D. T; EVERTS, M et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 2, pp 187-193, issn 0969-7128, 7 p.Article

Antibody directed enzyme prodrug ntherapyBAGSHAWE, K. D.Analytical proceedings. 1990, Vol 27, Num 1, issn 0144-557X, p. 5Article

Metal complexes as antitumour agentsKEPPLER, B. K; BERGER, M. R; KLENNER, T et al.Advances in Drug Research. 1990, Vol 19, pp 243-310, issn 0065-2490, 68 p.Article

Pharmaceutical applications of functionalized polymersPETRAK, K.Reactive polymers. 1989, Vol 10, Num 2-3, pp 231-237, issn 0923-1137, 7 p.Conference Paper

Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersionsMULET, Xavier; BOYD, Ben J; DRUMMOND, Calum J et al.Journal of colloid and interface science. 2013, Vol 393, pp 1-20, issn 0021-9797, 20 p.Article

Unified pinch approach for targeting of carbon capture and storage (CCS) systems with multiple time periods and regionsDIAMANTE, Joseph Angelo R; TAN, Raymond R; FOO, Dominic C. Y et al.Journal of cleaner production. 2014, Vol 71, pp 67-74, issn 0959-6526, 8 p.Article

Architecture, function and prediction of long signal peptidesHISS, Jan A; SCHNEIDER, Gisbert.Briefings in bioinformatics. 2009, Vol 10, Num 5, pp 569-578, issn 1467-5463, 10 p.Article

Response to Combined Molecular Targeting: Defining the Role of P-STAT3EGLOFF, Ann Marie; GRANDIS, Jennifer R.Clinical cancer research (Print). 2011, Vol 17, Num 3, pp 393-395, issn 1078-0432, 3 p.Article

Radioimmunotherapy of non-Hodgkin's lymphoma with ⁹⁰Y-DOTA humanized anti-CD22 IgG (⁹⁰Y-epratuzumab): Do tumor targeting and dosimetry predict therapeutic response?SHARKEY, Robert M; BRENNER, Arnold; CZUCZMAN, Myron S et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 12, pp 2000-2018, issn 0161-5505, 19 p.Article